Biogenesis and metabolism of Alzheimer's disease Aβ amyloid peptides

Peptides

Volumn 23, Issue 7, 2002, Pages 1285-1297

  Evin, Geneviève ^a   Weidemann, Andreas ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Amyloid; Peptide vaccine; Presenilin; Protease; Protease inhibitors; Secretase

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; ASPARTIC PROTEINASE; ASPARTYL PROTEASE BACE; ASPARTYL PROTEASE BACE 2; BACE INHIBITOR; BENZOFURAN DERIVATIVE; BETA SECRETASE; CLIOQUINOL; CONGO RED; DOXORUBICIN; ENDOTHELIN CONVERTING ENZYME; ENZYME INHIBITOR; ESTRADIOL; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; GELATINASE; HYPOCHOLESTEROLEMIC AGENT; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; PRESENILIN 1; PROTEIN KINASE C; RIFAMPICIN; SIMVASTATIN; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UNINDEXED DRUG; PROTEINASE; PROTEINASE INHIBITOR;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BIOGENESIS; CLEARANCE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; ENZYME REGULATION; HORMONE SUBSTITUTION; HUMAN; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; VACCINATION; ANIMAL; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE; REVIEW;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMAL; ENDOPEPTIDASES; HUMAN; PROTEASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS;

LEUCISCUS IDUS;

EID: 0035997231     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00063-3     Document Type: Article

References (182)

1. Platelets and DAMI megakaryocytes possess β-secretase-like activity
2. Uber eine eigenartige Erkrankung der Hirnrinde
3. Unusual phenotypic alteration of β-amyloid precursor protein (βAPP) maturation by a new Val-715→Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease
4. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
5. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP andcollagen type 1
6. Post-translational processing of β-secretase (BACE) and its ectodomain shedding: The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid Aβ production
7. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair Notch 1 proteolysis and nuclear translocation with relative preservation of Notch 1 signaling
8. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
9. Regulation of APP expression, biogenesis and metabolism by extracellular matrix and cytokines
10. Expression of active secreted forms of human-amyloid β-protein precursor by recombinant baculovirus-infected insect cells
11. α-2-Macroglobulin is genetically associated with Alzheimer disease
12. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein
13. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans
14. The amyloid precursor protein of Alzheimer's disease is released by human platelets
15. A novel zinc(II) binding site modulates the function of the βA4-amyloid protein precursor of Alzheimer's disease
16. Modulation of Aβ adhesiveness and secretase site cleavage by zinc
17. Evidence that tumor necrosis factor-α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor
18. BACE1 is the major β-secretase for generation of Aβ peptides by neurons
19. Protein phosphorylation regulates secretion of Alzheimer β/A4-amyloid precursor protein
20. The multiple paradoxes of presenilins
21. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
22. Aqueous dissolution of Alzheimer's disease Aβ-amyloid deposits by biometal depletion
23. Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease
24. Treatment with copper-zinc metal chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
25. Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization
26. Alzheimer's disease: Correlation of the suppression of β-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome
27. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
28. Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
29. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families
30. What the evolution of the amyloid protein precursor supergene family tells us about its function
31. Expression of the amyloid precursor protein of Alzheimer's disease on the surface of transfected HeLa cells
32. Alzheimer's disease amyloid β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits
33. Presenilins and Alzheimer's disease: Biological functions and pathogenic mechanisms
34. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): Cleavage of APP occurs in a late compartment of the default secretion pathway
35. Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein
36. A presenilin 1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
37. Functional gamma-secretase inhibitors reduce β-amyloid peptide levels in brain
38. Degradation of the Alzheimer's amyloid peptide by endothelin converting enzyme
39. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
40. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin 1
41. Alzheimer's disease amyloid precursor protein (AbPP): Proteolytic processing, secretases and βA4-amyloid production
42. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease βA4-amyloid: Possible involvement of cathepsin D
43. Presenilin I expression in yeast lowers secretion of the amyloid precursor protein
44. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease
45. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
46. Intra-neuronal compartments of the amyloid precursor protein
47. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein
48. Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype
49. Amyloid β interactions with chondroitin sulfate-derived monosaccharides
50. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid β precursor protein and amyloidogenic Aβ peptide formation
51. A 109-amino acid C-terminal fragment of Alzheimer's disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion
52. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
53. Alzheimer's disease: The amyloid cascade hypothesis
54. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
55. Mice with combined gene knockouts reveal essential and partially redundant functions of amyloid precursor protein family members
56. The βA4-amyloid precursor protein binding to copper
57. Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism
58. The expression and processing of human amyloid peptide precursors in Saccharomyces cerevisiae: Evidence for a novel endopeptidase in the yeast secretory system
59. Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
60. Identification of a novel aspartic protease (Asp 2) as β-secretase
61. The presenilins and Alzheimer's disease
62. Subcellular compartment and molecular subdomain of β-amyloid precursor protein relevant to the Aβ42-promoting effects of Alzheimer mutant presenilin 2
63. Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
64. Metabolic regulation of brain Aβ by neprilysin
65. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease
66. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
67. Statins and the risk of dementia
68. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
69. Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related
70. β-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin
71. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity
72. The carboxyl termini of β-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities
73. Isolation of baculovirus-derived secreted and full-length β-amyloid precursor protein
74. Membrane-anchored metalloprotease MDC-9 has an α-secretase activity responsible for processing the amyloid precursor protein
75. Elevated Aβ42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AβPP metabolism
76. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin-degrading enzyme
77. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid β by cathepsin D
78. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
79. The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases
80. Processing of the Alzheimer's disease amyloid precursor protein in Pichia pastoris: Immunodetection of α-, β-, and γ-secretase products
81. Secretion of Alzheimer's disease Aβ amyloid peptide by activated human platelets
82. The amyloid precursor protein of Alzheimer disease in human brain and blood
83. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state
84. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1
85. Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein
86. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
87. Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
88. Constitutive α-secretase cleavage of the β-amyloid precursor protein in the furin-deficient LoVo cell line: Involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM-10
89. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
90. Alzheimer's amyloid precursor protein produced by recombinant baculovirus expression. Proteolytic processing and protease inhibitory properties
91. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
92. Retention of the Alzheimer's amyloid precursor fragment c99 in the endoplasmic reticulum prevents formation of amyloid β-peptide
93. Requirement for presenilin 1 in facilitating lagged 2-mediated endoproteolysis and signaling of Notch 1
94. Amyloid plaque core protein in Alzheimer disease and Down syndrome
95. Degradation of Alzheimer's β-amyloid protein by human and rat brain peptidases: Involvement of insulin-degrading enzyme
96. Cell-free assays for gamma-secretase activity
97. Regulation of amyloid precursor protein cleavage
98. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth
99. The β-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation
100. Human brain βA4-amyloid protein precursor of Alzheimer's disease: Purification and partial characterization
101. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
102. Insulysin hydrolyzes amyloid β-peptides to products that are neither neurotoxic nor deposit on amyloid plaques
103. Characterization of the high affinity heparin-binding site of the Alzheimer's disease βA4-amyloid precursor protein (APP) and its enhancement by zinc(II)
104. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
105. γ-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid β-peptides of varying length
106. Presenilin 1 regulates pharmacologically distinct γ-secretase activities. Implications for the role of presenilin in γ-secretase cleavage
107. Effects of PS1 deficiency on membrane protein trafficking in neurons
108. Amino acid sequence RERMS represents the active domain of amyloid β/A4 protein precursor that promotes fibroblast growth
109. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G0
110. Identification of the Alzheimer β/A4-amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells
111. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II
112. Cleavage of Alzheimer's amyloid precursor protein by α-secretase occurs at the surface of neuronal cells
113. Alternative, non-secretase processing of Alzheimer's β-amyloid precursor protein during apoptosis by caspase 6 and 8
114. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β-peptides in brain
115. New protease inhibitors prevent gamma-secretase-mediated production of Aβ40/42 without affecting Notch cleavage
116. A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β-protein precursor
117. Apolipoprotein E
118. Mapping the APP/presenilin (PS) binding domains: The hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction
119. Cell surface β-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner
120. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation
121. α-2-Macroglobulin enhances the clearance of endogenous soluble β-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons
122. Cell surface presenilin 1 participates in the gamma-secretase-like proteolysis of Notch
123. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
124. Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A
125. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein
126. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease
127. Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein
128. Immunization with amyloid β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
129. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
130. Protease nexin-2/amyloid β-protein precursor. A tight-binding inhibitor of coagulation factor IXa
131. Presenilin 1 and 2 are molecular targets for gamma-secretase inhibitors
132. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
133. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
134. Secretion of β-amyloid precursor protein cleaved at the amino-terminus of the β-amyloid peptide
135. L-685,458, an aspartyl protease transition-state mimic, is a potent inhibitor of amyloid β-protein precursor gamma-secretase activity
136. Clearance of Alzheimer's amyloid Ab(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
137. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
138. Purification and cloning of amyloid precursor protein β-secretase from human brain
139. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing
140. A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP
141. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth
142. The role of presenilins in gamma-secretase activity: Catalyst or cofactor?
143. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein
144. Plaque busters: Strategies to inhibit amyloid formation in Alzheimer's disease
145. Alzheimer's disease amyloid precursor protein on the surface of cortical neurons in primary culture co-localizes with adhesion patch components
146. The amyloid precursor protein of Alzheimer's disease and the Aβ peptide
147. Presenilin is required for activity and nuclear access of Notch in Drosophila
148. An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (βAPP717) mutants
149. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease
150. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons
151. β-Amyloid precursor protein. Location of transmembrane domain and specificity of gamma-secretase cleavage
152. Generation of Alzheimer amyloid β-peptide through non-specific proteolysis
153. Inhibition of amyloid β-protein aggregation
154. Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein
155. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
156. Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme
157. Inhibiting amyloid precursor protein C-terminal cleavage promotes an interaction with presenilin 1
158. Ectodomain phosphorylation of β-amyloid precursor protein at two distinct cellular locations
159. Secretion of the β/A4-amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells
160. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4-amyloid protein
161. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin 2 and β-amyloid precursor protein
162. Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases
163. A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing
164. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures
165. Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42
166. Glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth
167. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease
168. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease
169. Two transmembrane aspartates in presenilin 1 required for presenilin endoproteolysis and γ-secretase activity
170. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
171. TGF-β1 promotes microglial amyloid β clearance and reduces plaque burden in transgenic mice
172. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease
173. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation
174. Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein
175. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides
176. Trafficking of cell surface β-amyloid precursor protein: Retrograde and transcytotic transport in cultured neurons
177. Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid β-peptide degradation
178. The pathogenesis of Alzheimer's disease. Is amyloid β-protein the beginning or the end?
179. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs
180. P. nicastrin modulates presenilin-mediated Notch/glp-1 signal transduction and βAPP processing
181. Proteolytic processing and secretion of human β-amyloid precursor protein in yeast secretase activity
182. Mice deficient for the amyloid precursor protein gene